Nasopharyngeal cancer (NPC) around the Mediterranean area: Standard of care

Critical Reviews in Oncology/Hematology

Volumn 84, Issue SUPPL. 1, 2012, Pages e106-e109

  Boussen, Hamouda ^a,b   Ghorbal, Lilia ^c   Naouel, Lejri ^a,b   Bouaouina, Noureddine ^d   Gritli, Said ^a   Benna, Farouk ^a   Daoud, Jamel ^c  

^a SALAH AZAIEZ INSTITUTE   (Tunisia)

^b ABDERRAHMAN MAMI HOSPITAL   (Tunisia)

^c HABIB BOURGUIBA HOSPITAL   (Tunisia)

^d FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Carcinoma; Chemotherapy; Concomitant; Disease free survival; Epidemiology; Mediterreanean area; Nasopharyngeal; Overall; Prognosis; Radiotherapy

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GENTAMICIN; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; VINCA ALKALOID;

AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER STAGING; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; HIGH RISK POPULATION; HUMAN; INDUCTION CHEMOTHERAPY; INTENSITY MODULATED RADIATION THERAPY; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CANCER; NORTH AFRICA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; SOCIAL STATUS; SOUTHERN EUROPE; STANDARDIZATION; SURVIVAL TIME;

EID: 84871696934     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2010.09.005     Document Type: Review

References (26)

1. Boussen H., Bouaouina N., Daldoul O., Benna F., Gritli S., Ladgham A. Update on medical therapies of nasopharyngeal carcinomas. Bull Cancer 2010, (April 13).
2. Tse L.A., Yu I.T.S., Mang O.W.K., Wong S.L. Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong. Br J Cancer 2006, 95:1269-1273.
3. Lee A.W., Poon Y.F., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992, 23:261-270.
4. Leung T.W., Tung S.Y., Sze W.K., et al. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck 2005, 27:555-565.
5. Busson P., Ooka T., Corbex M. Nasopharyngeal carcinomas and Epstein-Barr virus: from epidemiology and detection to therapy. Med Sci (Paris) 2004, 20:453-457.
6. Geara F.B., Nasr E., Tucker S.L., et al. Nasopharyngeal cancer in the Middle East: experience of the American University of Beirut Medical Center. Int J Radiat Oncol Biol Phys 2005, 61:1408-1415.
7. Yamouni M., Benhadji N.A., Beldjilali Y., et al. Phase II trial of Docetaxel and Cisplatin in locally advanced undifferentiated carcinoma of nasopharyngeal type. ECCO 12, Copenhagen, September 21-25 2003.
8. Sahraoui S., Acharki A., Benider A., Bouras N., Kahlain A. Nasopharyngeal carcinoma in children under 15 years of age: a retrospective review of 65 patients. Ann Oncol 1999, 10:1499-1502.
9. Selek U., Ozyar E., Ozyigit G., Varan A., Buyukpamukcu M., Atahan I.L. Treatment results of 59 young patients with nasopharyngeal carcinoma. Int J Pediatr Otorhinolaryngol 2005, 69:201-207.
10. Daoud J., Toumi N., Bouaziz M., et al. Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 2003, 39:2349-2354.
11. Ozyar E., Selek U., Laskar S., et al. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: a Rare Cancer Network study. Radiother Oncol 2006, 81:39-461.
12. Jmal A., Boussen H., Ghanem A., et al. Nasopharyngeal carcinoma in Tunisian children: retrospective epidemiological, clinical and biological study about 48 cases. Bull Cancer 2005, 92:977-981.
13. Daoud J., Toumi N., Siala W., Ghorbel A., Drira M.M., Frikha M. Results of a prospective randomised trial comparing conventional radiotherapy to split course bifractionated radiation therapy in patients with nasopharyngeal carcinoma. Radiother Oncol 2007, 85:17-23.
14. Kam M.K., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 2004, 60:1440-1450.
15. Lee N., Harris J., Garden A.S., et al. Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol 2009, 27:3684-3690.
16. Sham J.S., Choy D. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival. Head Neck 1991, 13:298-310.
17. Teo P., Shiu W., Leung S.F., Lee W.Y. Prognostic factors in nasopharyngeal carcinoma investigated by computer tomography-an analysis of 659 patients. Radiother Oncol 1992, 23:79-93.
18. Cvitkovic E., Bachouchi M., Boussen H., et al. Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases. J Clin Oncol 1993, 11:2434-2442.
19. Ahmad A., Stefani S. Distant metastases of nasopharyngeal carcinoma: a study of 256 male patients. J Surg Oncol 1986, 33:194-197.
20. Airoldi M., Gabriele A.M., Garzaro M., et al. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population. Radiother Oncol 2009, 92:105-110.
21. Ozturk B., Buyukberber S., Akmansu M., et al. The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma. Med Oncol 2008, 25:269-273.
22. Ferrari D., Chiesa F., Codecà C., et al. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study. Oncology 2008, 74:158-166.
23. Baujat B., Audry H., Bourhis J., et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients. Int J Radiat Oncol Biol Phys 2006, 64:47-56.
24. Bardet E., Bourhis J., Cals L., et al. Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy. Bull Cancer 2009, 96:1013-1028.
25. Varan A., Ozyar E., Corapçioĝlu F., Köksal Y., et al. Pediatric and young adult nasopharyngeal carcinoma patients treated with preradiation Cisplatin and docetaxel chemotherapy. Int J Radiat Oncol Biol Phys 2009, 73:1116-1120.
26. Hui E.P., Ma B.B., Leung S.F., et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol 2009, 27:242-249.